TScan Therapeutics Inc TCRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 02/02/23 EST
1.78UNCH (UNCH)
Volume
39,931
52 week range
1.45 - 5.60
Loading...
  • Open1.80
  • Day High1.84
  • Day Low1.72
  • Prev Close1.81
  • 52 Week High5.60
  • 52 Week High Date02/08/22
  • 52 Week Low1.45
  • 52 Week Low Date12/27/22

Key Stats

  • Market Cap42.862M
  • Shares Out24.08M
  • 10 Day Average Volume0.74M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change16.77

KEY STATS

  • Open1.80
  • Day High1.84
  • Day Low1.72
  • Prev Close1.81
  • 52 Week High5.60
  • 52 Week High Date02/08/22
  • 52 Week Low1.45
  • 52 Week Low Date12/27/22
  • Market Cap42.862M
  • Shares Out24.08M
  • 10 Day Average Volume0.74M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change16.77

RATIOS/PROFITABILITY

  • EPS (TTM)-2.58
  • P/E (TTM)-0.69
  • Fwd P/E (NTM)-0.64
  • EBITDA (TTM)-57.394M
  • ROE (TTM)-42.44%
  • Revenue (TTM)13.294M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-464.10%
  • Debt To Equity (MRQ)24.92%

EVENTS

  • Earnings Date03/09/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On TScan Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of T cell receptor-engineered T cell (TCR-T), therapies for the treatment of patients with cancer. The Company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. The...
Timothy Barberich
Non-Executive Independent Chairman
David Southwell
President, Chief Executive Officer, Director
Gavin Macbeath Ph.D.
Chief Scientific and Operations Officer
Brian Silver J.D.
Chief Financial Officer, Treasurer
Ann Hargraves
Vice President - Human Resources
Leiden Dworak CPA
Vice President - Finance
Address
880 Winter Street
Waltham, MA
02451
United States

Top Peers

SYMBOLLASTCHG%CHG
ISR
Isoray Inc
0.40UNCHUNCH
LPCN
Lipocine Inc
0.5489UNCHUNCH
SLDB
Solid Biosciences Inc
7.51UNCHUNCH
EIGR
Eiger BioPharmaceuticals Inc
2.15UNCHUNCH
HOOK
HOOKIPA Pharma Inc
1.01UNCHUNCH